selegiline has been researched along with Behavior Disorders in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 5 (35.71) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El Otmani, H; Fadel, H; Moutaouakil, F; Slassi, I | 1 |
| Miklya, I | 1 |
| Freedman, M; Kaye, ED; Petrovic-Poljak, A; Verhoeff, NP | 1 |
| Maruyama, W; Naoi, M | 1 |
| Newburn, D; Newburn, G | 1 |
| Gorman, JM | 1 |
| Baker, GB; Sowa, B; Todd, KG | 1 |
| Arai, Y; Fowler, CJ; Oreland, L; Stenström, A | 1 |
| Quinn, NP | 1 |
| Berry, MD; Juorio, AV; Paterson, IA | 1 |
| Kuhn, W; Müller, T | 1 |
| Berlin, F; Breakefield, XO; Eisenhofer, G; Ernst, M; George, T; Greenberg, BD; Murphy, DL; Sims, K; Zametkin, A | 1 |
| Davis, CM; Fuselier, CC; Goad, DL; Liem, P; McCormack, JR; Olsen, KM | 1 |
| Boyson, SJ | 1 |
7 review(s) available for selegiline and Behavior Disorders
| Article | Year |
|---|---|
[Slowing the age-induced decline of brain function with prophylactic use of (-)-deprenyl (Selegiline, Jumex). Current international view and conclusions 25 years after the Knoll's proposal].
Topics: Aging; Apoptosis; Brain; Cell Culture Techniques; Humans; Mental Disorders; Neurodegenerative Diseases; Neuroprotective Agents; Selegiline | 2009 |
Frontotemporal dementia and pharmacologic interventions.
Topics: Antidepressive Agents; Brain; Choline O-Acetyltransferase; Cholinesterase Inhibitors; Corpus Striatum; Dopamine; Frontotemporal Dementia; Galantamine; Humans; Mental Disorders; Neuroprotective Agents; Phenylcarbamates; Receptors, Serotonin; Rivastigmine; Selegiline | 2010 |
''70th Birthday Professor Riederer'' induction of glial cell line-derived and brain-derived neurotrophic factors by rasagiline and (-)deprenyl: a way to a disease-modifying therapy?
Topics: Animals; Brain-Derived Neurotrophic Factor; Dose-Response Relationship, Drug; Gene Expression Regulation; Glial Cell Line-Derived Neurotrophic Factor; Haplorhini; Humans; Indans; Mental Disorders; Monoamine Oxidase Inhibitors; Selegiline; Time Factors | 2013 |
Monoamine oxidase activity and localisation in the brain and the activity in relation to psychiatric disorders.
Topics: Animals; Brain; Clorgyline; Dopamine; Humans; Mental Disorders; Monoamine Oxidase; Selegiline; Subcellular Fractions | 1983 |
Anti-parkinsonian drugs today.
Topics: Amantadine; Amphetamines; Antiparkinson Agents; Brain Chemistry; Catechol O-Methyltransferase Inhibitors; Dopamine beta-Hydroxylase; Droxidopa; Humans; Kinetics; Levodopa; Mental Disorders; Parasympatholytics; Parkinson Disease; Selegiline | 1984 |
Possible mechanisms of action of (-)deprenyl and other MAO-B inhibitors in some neurologic and psychiatric disorders.
Topics: Aging; Alzheimer Disease; Animals; Cognition Disorders; Depressive Disorder; Humans; Longevity; Mental Disorders; Monoamine Oxidase Inhibitors; Nervous System Diseases; Parkinson Disease; Schizophrenia; Selegiline | 1994 |
The clinical potential of Deprenyl in neurologic and psychiatric disorders.
Topics: Adult; Aged; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Antidepressive Agents; Antipsychotic Agents; Child; Clinical Trials as Topic; Cross-Over Studies; Depression; Double-Blind Method; Humans; Mental Disorders; Middle Aged; Monoamine Oxidase Inhibitors; Narcolepsy; Nervous System Diseases; Neuroprotective Agents; Nootropic Agents; Parkinson Disease, Secondary; Schizophrenia; Selegiline; Supranuclear Palsy, Progressive; Tourette Syndrome; Treatment Outcome | 1996 |
1 trial(s) available for selegiline and Behavior Disorders
| Article | Year |
|---|---|
The use of selegiline in Alzheimer's patients with behavior problems.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Ambulatory Care; Cognition Disorders; Female; Home Nursing; Humans; Male; Mental Disorders; Middle Aged; Psychiatric Status Rating Scales; Selegiline; Single-Blind Method | 1991 |
6 other study(ies) available for selegiline and Behavior Disorders
| Article | Year |
|---|---|
[Severe apathy following head injury: improvement with Selegiline treatment].
Topics: Adolescent; Adult; Behavior; Bromocriptine; Craniocerebral Trauma; Dopamine Agonists; Emotions; Glasgow Coma Scale; Humans; Magnetic Resonance Imaging; Male; Mental Disorders; Monoamine Oxidase Inhibitors; Motivation; Prefrontal Cortex; Radiography; Selegiline | 2009 |
Selegiline in the management of apathy following traumatic brain injury.
Topics: Adult; Brain Injuries; Dopamine Agents; Female; Goals; Humans; Male; Mental Disorders; Motivation; Psychological Tests; Selegiline | 2005 |
Leading the way: advances in the diagnosis, treatment, and management of neuropsychiatric illnesses.
Topics: Administration, Cutaneous; Administration, Topical; Brain; Depressive Disorder, Major; Humans; Mental Disorders; Monoamine Oxidase Inhibitors; Phenelzine; Psychiatry; Selegiline; Somatoform Disorders; Tranylcypromine | 2006 |
Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders?
Topics: Amine Oxidase (Copper-Containing); Antidepressive Agents; Humans; Mental Disorders; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Phenelzine; RNA, Messenger; Selegiline; Tranylcypromine | 2007 |
Are MAO-A deficiency states in the general population and in putative high-risk populations highly uncommon?
Topics: Adolescent; Adult; Aged; Animals; Attention Deficit Disorder with Hyperactivity; Chromosome Deletion; Chromosome Mapping; Domestic Violence; Humans; Isoenzymes; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Mice; Mice, Transgenic; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Reference Values; Risk Assessment; Selegiline; Sex Offenses; X Chromosome | 1998 |
Psychiatric effects of selegiline.
Topics: Adult; Female; Humans; Mental Disorders; Middle Aged; Parkinson Disease; Selegiline | 1991 |